FDA approves Veru’s trial with Enobosarm to treat muscle loss associated with weight loss drugs
The FDA has cleared Veru’s Investigational New Drug (IND) application for its Phase 2b clinical study to evaluate enobosarm, an oral...
top of page
Browse by category
Search
Browse by tag
bottom of page